Live feed
Filing
SC 13G
SC 13G0001172661-17-000527·OrbiMed Capital GP VI LLC
Schedule 13G ownership disclosure
Xenon Pharmaceuticals Inc
Security class unavailable · CUSIP: 98420N105
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.5900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-17-000527
- Form type
- SC 13G
- Filer
- OrbiMed Capital GP VI LLC
- CIK
- CIK 1682115
- Filed
- Feb 13, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership